FMR LLC 13D and 13G filings for aTyr Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | aTyr Pharma, Inc. ATYR |
FMR LLC | 8,784,009 14.999% |
4,432,602 (+101.87%) |
Filing |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | aTyr Pharma, Inc. ATYR |
FMR LLC | 4,351,407 14.999% |
182,806 (+4.39%) |
Filing |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | aTyr Pharma, Inc. ATYR |
FMR LLC | 4,168,601 14.999% |
2,492,721 (+148.74%) |
Filing |
| 2021-07-12 12:07 pm Purchase |
2021-07-09 | 13G | aTyr Pharma, Inc. ATYR |
FMR LLC | 1,675,880 10.432% |
91,196 (+5.75%) |
Filing |
| 2021-04-12 1:05 pm Purchase |
2021-04-09 | 13G | aTyr Pharma, Inc. ATYR |
FMR LLC | 1,584,684 9.897% |
56,866 (+3.72%) |
Filing |
| 2021-02-08 10:15 am Purchase |
2021-02-05 | 13G | aTyr Pharma, Inc. ATYR |
FMR LLC | 1,527,818 14.999% |
1,036,369 (+210.88%) |
Filing |